These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 4910188)

  • 1. Depressive illness in a general practice. A demographic study and a controlled trial of imipramine.
    Porter AM
    Br Med J; 1970 Mar; 1(5699):773-8. PubMed ID: 4910188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxypertine in combination with imipramine: a controlled trial.
    Sim M; Gordon EB; Nicol CG
    J Int Med Res; 1978; 6(1):4-10. PubMed ID: 23973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amoxapine, imipramine and placebo in depressive illness.
    Smith RC
    Curr Ther Res Clin Exp; 1975 Aug; 18(2):346-53. PubMed ID: 809247
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyprolidol and imipramine: a double-blind controlled study in endogenous depression.
    Hekimian LJ; Gershon S; Floyd A
    Arzneimittelforschung; 1969 Jun; 19(6):955-6. PubMed ID: 4896165
    [No Abstract]   [Full Text] [Related]  

  • 5. A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in outpatients with major depression.
    March JS; Kobak KA; Jefferson JW; Mazza J; Greist JH
    J Clin Psychiatry; 1990 May; 51(5):200-2. PubMed ID: 2110560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of thyrotrophin releasing hormone versus placebo in combination with basic imipramine therapy of depressive patients].
    Benkert O; Lücke KH
    Arzneimittelforschung; 1976; 26(6):1162-4. PubMed ID: 822857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind comparative trial of dothiepin and imipramine for the treatment of depressive inpatients.
    Eilenberg D
    N Z Med J; 1980 Feb; 91(653):92-3. PubMed ID: 6991994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trazodone, a triazolopyridine derivative, in primary depressive disorder.
    Feighner JP
    J Clin Psychiatry; 1980 Jul; 41(7):250-5. PubMed ID: 6993447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mianserin in the treatment of depressive illness and anxiety states in general practice.
    Murphy JE
    Br J Clin Pharmacol; 1978; 5 Suppl 1(Suppl 1):81S-85S. PubMed ID: 341949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of continuation therapy with tricyclic antidepressants in depressive illness.
    Mindham RH; Howland C; Shepherd M
    Psychol Med; 1973 Feb; 3(1):5-17. PubMed ID: 4571148
    [No Abstract]   [Full Text] [Related]  

  • 11. [Depressions treated with imipramine-N-oxide and imipramine. A controlled double-blind trial].
    Ose E
    Tidsskr Nor Laegeforen; 1971 Nov; 91(33):2388-94. PubMed ID: 4943561
    [No Abstract]   [Full Text] [Related]  

  • 12. A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder.
    Stark P; Hardison CD
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):53-8. PubMed ID: 3882682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind multicentre trial comparing mianserin with imipramine.
    Pichot P; Dreyfus JF; Pull C
    Br J Clin Pharmacol; 1978; 5 Suppl 1(Suppl 1):87S-90S. PubMed ID: 341950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A controlled study of single-dose administration of imipramine pamoate in endogenous depression.
    Miller WC; Marcotte DB; McCurdy L
    Curr Ther Res Clin Exp; 1973 Oct; 15(10):700-6. PubMed ID: 4201314
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical efficacy of chlorpromazine-procyclidine combination, imipramine and placebo in depressive disorders.
    Fink M; Klein DF; Kramer JC
    Psychopharmacologia; 1965 Jan; 7(1):27-36. PubMed ID: 5318921
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of efficacy of amoxapine and imipramine in a multi-clinic double-blind study using the WHO schedule for a standard assessment of patients with depressive disorders.
    Takahashi R; Sakuma A; Hara T; Kazamatsuri H; Mori A; Saito Y; Murasaki M; Oguchi T; Sakurai Y; Yuzuriha T; Takemura M; Kurokawa H; Kurita H
    J Int Med Res; 1979; 7(1):7-18. PubMed ID: 369926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of major affective disorder with fluvoxamine.
    Lapierre YD; Browne M; Horn E; Oyewumi LK; Sarantidis D; Roberts N; Badoe K; Tessier P
    J Clin Psychiatry; 1987 Feb; 48(2):65-8. PubMed ID: 3100510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mianserin in the treatment of depression in general practice.
    Murphy JE; Donald JF; Molla AL
    Practitioner; 1976 Jul; 217(1297):135-8. PubMed ID: 792861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.
    Dominguez RA; Goldstein BJ; Jacobson AF; Steinbook RM
    J Clin Psychiatry; 1985 Mar; 46(3):84-7. PubMed ID: 3918993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Double-blind study of the antidepressive drugs (noxiptilin-imipramine)].
    Berner P; Guss H; Hofmann G; Kryspin-Exner K; Küfferle B
    Arzneimittelforschung; 1971 May; 21(5):638-40. PubMed ID: 4936793
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.